Focus area
Pharma Investment Firms
The RaiseHunt database lists 1,040 Pharma investment firms: 1,024 of them list a portfolio, 7,424 known investments between them and 3,650 people at those firms have a profile here. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in New York, Boston and London.
- 1,040
- Investment firms
- 1,024
- With a known portfolio
- 7,424
- Known investments
- 3,650
- People with a profile
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
1,040 Pharma investment firms
Showing 1-20
Filters
| Firm | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
IF Innovation Fund | United States | Venture capital | AIHealthcare | View fund | |
T TPG | San Francisco, United States | Private equityVenture debt | AIFinTech | View fund | |
M Morningside | Boston, United States | Private equityVenture capital | AIFinTech | View fund | |
B Bpifrance | Paris, France | Government-backed | AIClimate | View fund | |
LP Local Policy Innovation Partnership | London, United Kingdom | Government-backed | EducationHealthcare | View fund | |
MF MMV Financial | Toronto, Canada | Venture debt | FinTechHardware | View fund | |
H HealthCap | Stockholm, Sweden | Venture capital | FinTechHealthcare | View fund | |
IV IU Ventures | Indianapolis, United States | Syndicate / Angel group | AIConsumer | View fund | |
A Amethis | Paris, France | Private equity | ConsumerFinTech | View fund | |
CI California Institute for Regenerative Medicine | San Francisco, United States | Government-backed | EducationHealthcare | View fund | |
EN Eureka Network | Lisboa, Portugal | AcceleratorGovernment-backed | ClimateFood | View fund | |
HV Handshake Ventures | San Francisco, United States | Venture capital | AICommerce | View fund | |
KC Keystone Capital | Chicago, United States | Private equity | AIClimate | View fund | |
M Mitsubishi | Tokyo, Japan | Corporate VCPrivate equity | AIClimate | View fund | |
TA Timepolio Asset Management | Private equityVenture capital | HealthcareSaaS | View fund | ||
EL Eli Lilly and Company | Indianapolis, United States | Corporate VC | AIHealthcare | View fund | |
I Invus | New York, United States | Family OfficeFund of funds | AICommerce | View fund | |
PV Panacea Venture | United States | AcceleratorVenture capital | AIConsumer | View fund | |
AI Access Industries | New York, United States | Private equityVenture capital | ConsumerHealthcare | View fund | |
DC Delos Capital | New York, United States | Private equityVenture capital | Healthcare | View fund |
900 of 1,040 Pharma investment firms, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A106
- AbbVie
- Abc International
- Aberdeen
- Aberdeen Dynamics
- Abingworth
- ABS Ventures
- Acacia Research
- Accelerator Life Science Partners
- Ackermans & van Haaren
- Acorn Bioventures
- Activation Capital
- ADAR1 Capital Management
- AdBio partners
- Addex Therapeutics
- Aditum Bio
- Adjuvant Capital
- Admaius Capital Partners
- Advantech Capital
- Advent Life Sciences
- Affinity Asset Advisors
- Agile Capital
- Aglaia Oncology Funds
- Ahn-Gook Pharmaceutical
- Aiac Investment Group
- Aier Eye Hospital Group
- Aihc Capital
- Aks Capital
- Alaska Permanent Fund
- Alcon
- Alethea Capital Management
- Alexandra Invest
- Alexandria Real Estate Equities
- Alexion Pharmaceuticals
- Alfresa Holdings
- Alkem Laboratories
- Allostery Investments
- Ally Bridge Group
- Almirall
- Alpha Blue Ocean
- Alpha Compute
- Alpha Wave Global
- ALS Investment Fund
- ALSA Ventures
- Altium Capital
- Alto Partners SGR
- Altus Capital Partners
- Amanzi Capital
- aMoon Fund
- Amplitude Ventures
- Amr Action Fund
- Amylin Pharmaceuticals
- Amzak Health Investors
- AN Venture Partners
- Andbank
- Andera Partners
- Angel
- Angel Physicians Fund
- AngelCentral
- Angelor
- Angels Santé
- Animal Health Angels
- Aperture Venture Capital
- Apjohn Ventures
- Apollo Health Ventures
- Apollo Ventures Group
- Apple Tree Partners
- Apposite Capital
- Aquilo Capital Management
- Aravis SA
- ARAX Capital Partners
- Arboretum Ventures
- Arcano
- Archimed
- Arcus Investment
- Arcus Partners
- Argenx
- Argobio Studio
- Ariel Savannah Angel Partners
- Arkin Holdings
- Armistice Capital
- Armònia SGR
- Asahi Kasei
- Ascendiant Capital Markets
- Ascent Biomedical Ventures
- Ascenta Capital
- Asha Impact
- ASP Isotopes
- Aspire Capital Partners
- Asset Management Company
- Asset Management Partners
- Astellas Pharma
- Astorg
- AstraZeneca
- Asymchem Laboratories (tianjin)
- AtaiBeckley
- Atem Capital Fund
- Athyrium Capital Management
- Auriga Partners
- Aurora Cannabis
- Avego
- Avidity Partners
- Avista Healthcare Partners
- Avoro Capital
- Axil Capital Partners, Axil Capital Advisors K.k.
- Ayuh Ventures
- Azimuth Opportunity Fund
B57
- BancoBPM
- Bank Clariden Leu
- Baselaunch
- Bat
- Baxalta
- Bay City Capital
- Bayland Capital
- Becker Ventures
- Beecken Petty O'Keefe & Company
- BeiGene
- Bellco Capital
- Bespoke Growth Partners
- Bgv (biogeneration Ventures)
- Bija Ventures
- BioAdvance Capital
- Biocon
- Biogen
- Bioluminescence Ventures
- BioMedPartners
- Bionova Capital
- Bioqube Ventures
- BioRock Ventures
- Bios Partners
- Biotechnology Industry Research Assistance Council (BIRAC)
- BioTrack Capital
- Biovance Capital
- BioVeda China Fund
- BioVentures Investors
- Birk Venture
- Blackbird Laboratories
- Bloom Burton & Co.
- Blue Chip Venture Company
- Blue Ocean Capital
- Blue Owl Capital
- Bluestem Capital
- Bluewater Angel Investor Group
- Bohe Angel Fund
- Borealis Ventures
- Bosera Capital
- Boxer Capital Management
- Boyu Capital
- Bpifrance
- Brace Pharma Capital
- BRAIN Biotech
- Brand Capital, India
- Breakthrough
- BRESLIN
- BridgeBio
- Brightedge - American Cancer Society
- Brightgene
- Brii Biosciences
- British Patient Capital
- Broadfin Capital
- Broadview Ventures
- Business Angels Switzerland
- BVM Capital
- BVP (Brightlands Venture Partners)
C94
- C-Bridge Capital
- Caligan Partners
- Calyx Bio-ventures
- Cambrian Bio
- Camford Capital
- Cancer Focus Fund
- Cane Investment Partners
- Cape Fear Biocapital
- Capital Cell
- Capital Dynamics
- Capiton
- Capstone Partners Co.
- CapVest
- Carb-x
- Care Capital
- Carnegie Investment Bank
- Casa Verde Capital
- Casdin Capital
- CASI Pharmaceuticals
- Catalys Pacific
- Catalytic Impact Foundation
- Catalyze Capital
- Cauris Management
- CBC Group
- Cdg Capital
- CDG Invest Growth
- CDH Investments
- CDP Cassa Depositi e Prestiti
- Celerity Partners
- Celgene
- Celltrion
- Center Ventures
- Centurium Capital
- Charlottesville Angel Network
- Charter Life Sciences
- Charterhouse Capital Partners
- Chazen Capital Partners
- Chemical Angel Network
- Chenel Capital Partners
- Chicago Growth Partners
- China Cinda Asset Management
- China Development Industrial Bank (cdib)
- China Life Insurance
- China Life Investment Holding
- Chiyoda
- Chong Kun Dang Pharmaceutical
- CinRx Pharma
- Cinven
- CIP Capital
- Cj Logistics
- Clarion Capital Partners
- Claris Ventures
- Clarus Ventures
- Clinical Research Ventures
- Cmb International Capital
- CMIA Capital Partners Pte.
- Coalition For Epidemic Preparedness Innovations
- COBRO VENTURES
- Codexis
- Codon Capital
- Cofounder VC
- Collage Partners
- Colorcon
- Colt Ventures
- Columbus Venture Partners
- Commodore Capital
- Company K Partners
- Convergent Ventures
- Cormorant Asset Management
- Cormorant Capital
- Cowin Capital
- CQDM
- Creacion Ventures
- Creador
- Crédit Mutuel Innovation
- CRG
- Criteria Bio Ventures
- Crocker Ventures
- Crohn's & Colitis Foundation
- Cronos Group
- Crosstree
- CS Capital Management
- CSL
- CTI Capital Securities
- CTI Life Sciences Fund
- Cure EB
- CureDuchenne Ventures
- Curie Capital
- Curie.Bio
- CVS Pharmacy
- CX Partners
- Cybernaut Venture Capital
- Cystic Fibrosis Foundation
- Cytokinetics
D28
- Dafna Capital Management
- Daiichi Sankyo Japan
- Darby Technology Ventures
- DaVita Kidney Care
- DaVita Venture Group
- Dawn Biopharma
- Dayli Partners
- DC Thomson
- Deep Science Ventures
- Deep Track Capital
- Deutsche Ventures
- Development Partners International (DPI)
- Dexcel Pharma
- Diamond Biofund
- Diamond Capital Company
- Diamond Capital Management
- Diatonic Healthcare
- Dnv Capital
- Domain Associates
- Dompé
- Double Point Ventures
- Drads Capital
- Dreavent
- Driehaus Capital Management
- Droia Ventures
- DuPont
- Duquesne Capital Management
- Dyadic International
E37
- E Squared Capital Management
- EAI Investments
- Early Stage Venture Partners
- East West Capital Partners
- EcoR1 Capital
- Efung Capital
- Eir Ventures
- Elahi Group Of Companies
- Elan
- Eli Lilly and Company
- Elikon Venture
- Elite Capital
- EMD Financial
- EMZ Partners
- Enavate Sciences
- Endless
- Endpoint Ventures
- Enhanced Healthcare Partners
- Envest
- Eos Capital
- Epidarex Capital
- EQT
- Eqt Life Sciences
- Equity Group Investments
- Esperante Ventures
- Essex Bio-technology
- Eurofarma
- Eventide
- Eventide Asset Management
- Everis
- Everstone
- Everstone Capital
- Excel Venture Management
- Exitfund
- Exome Asset Management
- Exponent
- Express Scripts
F39
- Fåhraeus Startup & Growth
- Fairmount Funds Management
- Fairmount Partners
- Famy Care Ltd., Mumbai
- Farallon Capital Management
- Farmak
- Fast Track Initiative
- FC Capital
- Ferrer Freeman & Company
- Fiera Private Debt
- Finchley Healthcare Ventures
- First Flight Venture Center
- First Light Asset Management
- First Manhattan Consulting Group
- Flagship Ventures
- Flerie Invest
- Fletcher Spaght
- Floridienne Group
- Fondazione Telethon
- Forbion
- Foreground Capital
- Forge Life Science Partners
- Fortune Network Capital
- Forty51 Ventures
- Forward Ventures
- Fosun Health Capital
- Fosun Pharma
- Foundation Fighting Blindness
- Fox Chase Cancer Center
- Frazier Healthcare Partners
- Frazier's Funding Partners
- Freeflow Ventures
- Friulia Finanziaria Fvg
- Froedtert Health
- Frontier Ip Group
- Fubon Financial Holding Co., Ltd. 富邦金控
- Fuji Pharma Co.
- Fund+
- FUTURX
G26
- G Square Healthcare Private Equity
- Galen Partners
- Gardner Standard
- Genentech
- General Inception
- Genesys Capital
- Genextra
- GHO Capital Partners
- Ghr Foundation
- Gilde Equity Management
- Gilead Group
- Gilead Sciences
- Gl Capital
- Global BioAccess Fund
- Global Source Ventures
- Gordonmd Global Investments
- Gouvernement
- Grand Industrial
- Grand Palmetto Capital Partners
- Great Point Partners
- Green Cross
- Gründerfonds Ruhr
- GSK
- Gulf South Angels
- Guoqian Venture Capital
- Gurnet Point Capital
H33
- H&q Asia Pacific
- Hadean Ventures
- Halifax Group
- HanAll Biopharma
- Handelsbanken Fonder
- Hankang Capital
- Hanne Capital
- HAO Capital
- Harvest Global Investments
- Hatch
- HB Ventures/ 木槿资本
- HBM Partners
- Health | Santé
- Health Innovation Capital
- HealthCare Royalty
- HealthCare Ventures
- Healthequity, SCR
- Healthspan Capital
- Heda Ventures
- Heidelberg Innovation
- Heights Capital Management
- Helix Funds
- Hermed Capital
- Highcape Capital
- Highlight
- Highline Capital Management
- Honghui Capital
- HSBC Venture Capital Coverage Group
- Huarong Rongde Asset Management
- Hudson Bay Capital Management
- Humanwell
- Hunt Partners
- Huons
I37
- IFLI - Institute for Follicular Lymphoma Innovation
- IK Partners
- IKB Deutsche Industriebank
- Imm Private Equity
- Imo Ventures
- Impact Fund Denmark (formerly IFU)
- Impilo
- Incuba Venture
- Incube Ventures
- Incyte
- Indaco Venture Partners
- India Alternatives Private Equity Fund
- Indonesia Investment Authority (INA)
- Industrial and Commercial Bank of China
- Industrial Bank
- Infinity Equity
- Inkef
- Innobio
- Innovent Biologics
- Inspira Financial
- Integra Holdings
- Intera Partners
- InvAscent
- Inveni Capital
- Inventages Venture Capital Investment
- Investindustrial
- Investissement Québec
- Investissement Québec
- Investissement Québec
- INVESTSUD
- Inviga Healthcare Fund
- InVivium Capital
- Invivo Partners
- Ionis Pharmaceuticals
- Ipf Partners
- Isis Capital Management
- Israel Japan Fund
J16
- J17 Ventures
- Jabil
- James Richardson & Sons
- Janchor Partners
- Janus Henderson Investors
- JDRF T1D Fund
- JEITO
- Jennison Associates
- Jianxin Capital
- Jifeng Ventures
- JLS Fund
- Jmcr Partners
- JSR
- Junson Capital
- JW ASSET MANAGEMENT
- JW Pharmaceuticals
K18
- K2 & Associates
- K2 HealthVentures
- K2 Venture Partners 险峰淇云
- Kainova Therapeutics
- KB Financial Group
- Kearny Venture Partners
- Keiretsu Forum Northwest
- Kerna Ventures
- Kineticos Disruptor Fund
- Kingdon Capital
- Knight Therapeutics
- Kohlberg & Company
- Korea Investment Accelerator
- Kotak Investment Advisors
- Kpc
- Kuwait Life Sciences Company
- KVP Capital
- Kyoto University Innovation Capital
L34
- LA WY Capital Partners
- Lacuna Holdings
- Lake Bleu Capital
- Lang Sheng Investment
- Lanting Capital
- Latterell Venture Partners
- Laurion Capital Management
- Ld Pensions
- Leafy Tunnel
- Leerink Partners
- Leidos
- LG Chem
- Lichen Ventures
- Lichtsteiner Foundation
- Life Insurance
- Life Science Invest
- Lifelink Ventures
- Lifespan Vision Ventures
- Ligand Pharmaceuticals
- Lilly Asia Ventures 礼来亚洲基金
- Lilly Ventures
- Limitless Ventures
- Liquid Ventures
- Longevity Vision
- LongRiver Investments
- Longwater Investment
- Longwood Fund
- Lonza
- Lotte Hb
- Lovett Miller & Co.
- Lumeira Ventures
- Lumira Ventures
- Luye Pharma
- Lyra Ventures
M45
- M Ventures
- M&g Investments
- Macandrews & Forbes
- Madryn Asset Management
- Maven Investment Partners Us
- Maxpro Ventures
- Mayne Pharma
- McDonald Partners
- McKesson
- Med-fine Capital
- MedImmune
- Mediterrania Capital Partners
- Meneldor
- Mentor Capital
- Mentor Capital Network
- Merck Group
- Mercy Health
- Merida Capital Holdings
- Merifin Capital
- Merz Therapeutics
- Mesa Verde Venture Partners
- Metric Capital Partners
- Midas Asset
- Milestone Capital
- Milestone Electric, Air & Plumbing
- Militia Hill Ventures
- Milky Way Ventures
- Mingxin China Growth Fund
- Mirae Asset Capital Life Science
- Miramar Equity Partners
- Mission Bay Capital
- Mission BioCapital
- Mission Gate
- Mitre Ventures
- Mitsui & Co. Global Investment
- Monash University Career Connect
- Monashee Investment Management
- Monograph Capital
- Montis Capital
- Montis Capital Group
- MP Healthcare Venture Management
- MQB Partners
- MTEC | Medical Technology Enterprise Consortium
- MTPConnect
- Multiple Myeloma Research Foundation
N36
- N+1 Capital
- Nan Fung Group
- NantWorks
- National Cancer Research Institute
- National Institute on Drug Abuse (NIDA)
- National Securities
- Nautic Partners
- Naxicap Partners
- Negev Capital
- Neo Kuma Ventures
- Neomed Management
- Nest.Bio
- Nestlé Health Science
- New Alliance Capital
- New Harbor Capital
- New Industry Ventures
- New Rhein Healthcare Investors
- Newlife Capital
- Newpath Management
- NEXTBio Capital
- NEXUS CVC Partners
- NH Investment & Securities
- Nice & Green Sa
- NIPPON SHOKUBAI
- Noble Capital Markets
- Nordic Capital
- NorgesInvestor
- Norgine Ventures
- Novalis Lifesciences
- NovaQuest Capital Management
- Novartis Institutes for Biomedical Research
- Novartis Venture Fund
- Novo
- Novo Nordisk
- Nowture
- NVCC
O13
- Oberland Capital
- Ocama Partners
- Occident
- Octagon Capital Advisors
- October Capital
- Omega Funds
- OPKO Health
- Organigram
- Origin Pioneering
- Oriola
- OUVC - OSAKA University Venture Capital
- Oxford Bioscience Partners
- Oxford Finance
P50
- Pacific Bridge NY
- Pacific Rim Ventures
- PAG
- Palo Alto Investors
- Panacea Capital
- Panorama Capital
- Paperboy Ventures
- Paradigm Biocapital Advisors
- Paragon Biosciences
- Paratus Investment
- Parent Project Muscular Dystrophy
- Parkman Healthcare Partners
- Parquest
- Partners Group
- Patient Square Capital
- Paul Capital
- Paula and Rodger Riney Foundation
- PeptiDream
- Perceptive Advisors
- Persephoni Bio
- Perseverance Capital
- Petrichor Asset Management
- Pharmakon Advisors
- Phoenix IP Ventures
- Photon Fund
- Pierre Fabre
- Ping An Ventures
- Piramal Alternatives
- Piramal Group
- Pivotal bioVenture Partners
- Pivotal Life Sciences
- Platanus Technology Pvt
- Pleasant Bay Capital Partners
- Point72
- Polar Capital
- Polaris Founders Capital
- Pontifax Venture Capital
- Portal Innovations
- PPD
- Praxis Capital Partners
- Prevail Partners
- Private Debt Partners
- Priveq
- Proparco
- Propel Bio Partners
- Prospect Hill Growth Partners
- PSQ CAPITAL
- Ptv Healthcare Capital
- Purdue Pharma
- PureTech Health
Q3
- Qiming Venture Partners USA
- Quaker Partners
- Quan Capital
R27
- RA Capital Management
- Rad Biomed Accelerator
- Reckitt
- Recordati
- Red Abbey Venture Partners
- Redhill Capital
- Redmile Group
- Rellim Capital Management
- Remiges Ventures
- Renaissance Venture Capital
- Resilience
- RF Investment Partners
- Richland Equities
- Ridgeback Capital
- RiverVest Venture Partners
- RM Global Partners
- Roche
- Rock Springs Capital
- Rohto Pharmaceutical
- Rosalind Advisors
- Rosetta Capital
- RoundTable Healthcare Partners
- Royalty Pharma
- RPG Group
- RS Participaties
- RTW Investments
- Russell Westbrook Enterprises
S77
- Sagard Wealth
- Sahsen Ventures
- Salem Partners
- Sambrinvest
- Samlyn Capital
- Samsara BioCapital
- Sangel
- Santen
- Saras Capital
- Sarepta Therapeutics
- Sarsia Seed Management
- Sartorius
- SBH BioFoundry
- Scaling Care
- Schonfeld
- Schrödinger
- SCI Ventures
- Scientia Ventures
- Sciety
- Sectoral Asset Management
- Serial Stage Venture Partners
- Seroba Life Sciences
- Shanghai Pharmaceutical
- Shinhan Capital
- Shionogi
- Signet Healthcare Partners
- Silk Road Fund
- Sinopharm-cicc
- Sinovac Biotech
- Sirnaomics
- Sirona Capital
- Sixth Element Capital
- Sixty Degree Capital
- Sk Capital Partners
- Skoll Foundation
- Skyline Capital
- Skyline Ventures
- Slate Path Capital
- Snbl
- SODENA
- Sofinnova Investments
- Sofinnova Partners
- Solaris Ventures
- Soleus Capital Management
- Somerset Indus Capital Partners
- Sorrento Therapeutics
- Sound Bioventures
- Source Capital
- Southern Research
- SPE Capital
- Sphera Partners
- Sporos Bioventures
- Sprim Global Investments
- Spring Ridge Ventures
- SR One Capital Management
- Star Capital Sgr
- Star Legend FO
- State Development & Investment
- Stellum Capital
- Stephen Industries
- Stonebridge Capital
- Summit Agricultural Group
- Sunstone Life Science Ventures
- Superstring Capital
- Surveyor Capital
- Suvretta Capital Management
- Suzhou Industrial Park
- SV Health Investors' Dementia Discovery Fund (DDF)
- SV Health Investors' Dementia Discovery Fund (DDF)
- Swanbridge Capital
- Swiss Life Private Equity Partners
- SWK Holdings
- Symbiosis
- Syncona Partners
- Syncona Partners
- Synergenics
- Syno Capital
T46
- T1D Fund
- Tachyon Ventures
- Taihill Venture
- Taiho Pharmaceutical Co., Ltd.
- Taiho Ventures
- Taikang Asset
- Takeda
- Takeda
- Tako
- Tang Capital Management
- Tao Capital
- Tavistock Life Sciences
- Taxim Capital Private Equity
- TCGX
- Techgrowth Ohio
- Technion Research & Development Foundation
- Tekla Capital Management
- Tellus Bioventures
- Tenmile
- Terra Magnum Capital Partners
- Teva Pharmaceuticals
- TF Capital
- The ALS Association
- The Column Group
- The Global Emerging Markets Group (GEM)
- The Innovestors
- The Leukemia & Lymphoma Society’s Therapy Acceleration Program
- The National Institutes of Health
- The Silverstein Foundation for Parkinson's with GBA
- The Walden Group
- Third Rock Ventures
- Thirdrock Group
- Thomas Weisel Venture Partners
- Thynk Ventures
- Tigermed
- Tikehau Capital
- TO VC
- Trails Edge Capital Partners
- Triathlon Medical Venture Partners
- Trill Impact
- Trinity Innovation Fund
- Triton Funds
- True North Fund
- Ts Investment
- Turret Capital Management
- Tybourne Capital Management
U14
- UF Innovate | Ventures
- Ulysses Diversified Holdings
- Unicorn Capital Partners
- Union Investment Partners
- Unionen
- Uniseed
- Unison Capital
- University Of Helsinki
- University of Notre Dame - College of Arts & Letters
- University of Pennsylvania
- University of Vermont Health
- US Army Corps of Engineers
- UT Austin Research
- Utrecht Holdings
V20
- Vatera Healthcare Partners
- venBio
- Ventac Partners
- Ventures West
- Verition Fund Management
- Versant Ventures
- Vertex Pharmaceuticals
- Vertex Ventures HC
- Vesalius Biocapital IV
- Vesey Street Capital Partners
- VI VENTURES
- VIC Tech
- Victoria Capital Partners
- Vida Ventures
- Vie Ventures
- Viking Global Investors
- Visionary Venture Fund
- Viva Bioinnovator
- Viva Bioinnovator
- Viva Ventures
W16
- WAD Capital
- Water Street Healthcare Partners
- Webster Equity Partners
- Wellington Management
- Werth Ventures
- Westlake BioPartners®
- WestRiver Group
- White Manna Capital Partners
- White Oak Healthcare Finance
- William Harris Investors
- Windamere Venture Partners
- WindRose Health Investors
- Winnow Fund
- Woodline Partners
- Woodward Angels
- Wuxi Biologics
X5
- Xesgalicia
- Xiamen C&D
- XISTA Science Ventures
- Xontogeny
- Xsml
Y6
- Yfy Biotech Management Company
- Yk Bioventures
- Yosemite
- Yuanming Capital
- Yuhan
- Yuvaan Tiwari Foundation
Z4
- Zcube
- Ziff Capital Partners
- ZQ Capital
- Zynext Ventures
#13
- [BVM]12
- 10X Venture Partners
- 1315 Capital
- 3B Future Health Fund
- 3B Future Health Fund I & II
- 3E Bioventures Capital
- 3E Bioventures Capital
- 3h Health Investment
- 3SBio
- 4BIO Capital
- 54 Capital
- 5AM Ventures
- 株式会社dinii
Frequently asked questions
How many Pharma investment firms are on RaiseHunt?
RaiseHunt lists 1,040 Pharma investment firms.
How many of them have a known portfolio?
1,024 of the 1,040 firms list at least one portfolio company, 7,424 known investments between them.
Who can I reach at these firms?
3,650 people working at them have a profile here, each with their role at the firm and whether an email address is on file.
Where are most Pharma investment firms based?
The largest concentrations are in New York, Boston and London.
What rounds do Pharma investment firms take part in?
Most list Seed and Series A among their stages.
How do I contact Pharma investment firms?
Every firm page shows whether an email address is on file, and the named contacts at that firm. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Pharma investment firms free to browse?
Yes. The directory and every firm page are free to read. Matching your own startup against them requires an account.
Do Pharma funds only back Pharma companies?
No. A focus area is a signal of interest, not a restriction. Firms usually list several, and the useful question is whether the existing portfolio looks like the kind of company you are building.
How does a decision get made inside a firm?
Usually by a group rather than by the person you first spoke to. One partner sponsors the deal internally and takes it to the rest, which is why the process runs longer than an angel conversation and why a single enthusiastic meeting is not yet a commitment.
Does the location of a firm matter?
Less than it used to. Plenty of firms back companies outside their own city, and remote first meetings are normal. Being nearby helps with introductions and later conversations, but it is rarely the thing that decides an investment.
What if no firm on this list replies?
Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.
What is the difference between raising from a firm and raising from an angel?
An angel invests their own money and can decide alone, which usually makes the process shorter. A firm invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a firm once there is more to show.
Who should I contact at Pharma investment firms?
A named partner or principal, not a general company address. Investment decisions sit with individual people, and a message that lands in a shared inbox usually stops there. Each fund page here lists the people we hold a profile for, with their role at the firm.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal